Literature DB >> 15629009

Endothelin in health and disease.

Emina Nakas-Ićindić1, Asija Zaciragić, Almira Hadzović, Nesina Avdagić.   

Abstract

Endothelin is a recently discovered peptide composed of 21 amino acids. There are three endothelin isomers: endothelin-1 (ET-1), endothelin-2 (ET-2) and endothelin- 3 (ET-3). In humans and animals levels of ET-1, ET-2, ET-3 and big endothelin in blood range from 0,3 to 3 pg/ml. ET-1, ET-2 and ET-3 act by binding to receptors. Two main types of the receptors for endothelins exist and they are referred to as A and B type receptors. Different factors can stimulate or inhibit production of endothelin by endothelial cells. Mechanical stimulation of endothelium, thrombin, calcium ions, epinephrine, angiotensin II, vasopressin, dopamine, cytokines, growth factors stimulate the production of endothelin whereas nitric oxide, cyclic guanosine monophosphate, atrial natriuretic peptide, prostacyclin, bradykinin inhibit its production. Endothelins have different physiological roles in human body but at the same time their actions are involved in the pathogenesis of many diseases. The aim of this review was to present some of, so far, the best studied physiological roles of endothelin and to summarize evidence supporting the potential role of ET in the pathogenesis of certain diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15629009      PMCID: PMC7245481          DOI: 10.17305/bjbms.2004.3381

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  24 in total

Review 1.  Endothelin and endothelin receptor antagonists in heart failure.

Authors:  Barry H Greenberg
Journal:  Congest Heart Fail       Date:  2002 Sep-Oct

Review 2.  Endothelin, a novel endothelium-derived peptide. Pharmacological activities, regulation and possible roles in cardiovascular control.

Authors:  M Yanagisawa; T Masaki
Journal:  Biochem Pharmacol       Date:  1989-06-15       Impact factor: 5.858

3.  Plasma levels of endothelin and early carotid atherosclerosis in diabetic patients.

Authors:  I N Migdalis; K Kalogeropoulou; K D Karmaniolas; N Varvarigos; G Mortzos; P Cordopatis
Journal:  Res Commun Mol Pathol Pharmacol       Date:  2000 Jul-Aug

4.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

5.  [The effects of endothelin-1 and selective endothelin receptor-type A antagonist on human renal interstitial fibroblasts in vitro].

Authors:  Xuefei Tian; Gongyao Tang; Yipu Chen
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2002-01-10

6.  Chronic endothelin receptor blockade prevents renal vasoconstriction and sodium retention in rats with chronic heart failure.

Authors:  Shuang-Shuang Ding; Changbin Qiu; Patrick Hess; Jian-Fei Xi; Jean-Paul Clozel; Martine Clozel
Journal:  Cardiovasc Res       Date:  2002-03       Impact factor: 10.787

7.  Doxorubicin, an RNA synthesis inhibitor, prevents vasoconstriction and inhibits aberrant expression of endothelin-1 in the cerebral vasospasm model of the rat.

Authors:  M G Mostafa; T Mima; T Taniguchi; K Mori
Journal:  Neurosci Lett       Date:  2000-04-14       Impact factor: 3.046

Review 8.  The role of endothelin in proximal tubule proton secretion and the adaptation to a chronic metabolic acidosis.

Authors:  Kamel Laghmani; Patricia A Preisig; Robert J Alpern
Journal:  J Nephrol       Date:  2002 Mar-Apr       Impact factor: 3.902

Review 9.  Effects of bosentan on cellular processes involved in pulmonary arterial hypertension: do they explain the long-term benefit?

Authors:  Martine Clozel
Journal:  Ann Med       Date:  2003       Impact factor: 4.709

10.  Effect of endothelin-1 on glomerular hydraulic pressure and renin release in dogs.

Authors:  H Lin; M Sangmal; M J Smith; D B Young
Journal:  Hypertension       Date:  1993-06       Impact factor: 10.190

View more
  2 in total

1.  Expression pattern of endothelin system components and localization of smooth muscle cells in the human pre-ovulatory follicle.

Authors:  Dong-Hee Choi; Eun Kyung Kim; Kyeoung-Hwa Kim; Kyung-Ah Lee; Dong-Wook Kang; Hey Young Kim; Phillip Bridges; Chemyong Ko
Journal:  Hum Reprod       Date:  2011-03-15       Impact factor: 6.918

2.  Endothelin-1 promotes cardiomyocyte terminal differentiation in the developing heart via heightened DNA methylation.

Authors:  Alexandra Paradis; Daliao Xiao; Jianjun Zhou; Lubo Zhang
Journal:  Int J Med Sci       Date:  2014-02-20       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.